Chemical Structure : Ironomycin
货号: PC-72335Not For Human Use, Lab Use Only.
Ironomycin (Ironomycin AM5) is a lysosomal iron-targeting small molecule that reduces the mitochondrial iron load, resulting in the potent disruption of mitochondrial metabolism.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Ironomycin (Ironomycin AM5) is a lysosomal iron-targeting small molecule that reduces the mitochondrial iron load, resulting in the potent disruption of mitochondrial metabolism, induces ferroptosis in cancer cells.
Ironomycin promotes the recruitment and activation of BAX/BAK, but the resulting mitochondrial outer membrane permeabilization (MOMP) does not lead to potent activation of the apoptotic caspases, nor is the ensuing cell death prevented by inhibiting the previously established pathways of programmed cell death.
Ironomycin exhibits marked in vitro and in vivo synergy with venetoclax and overcomes venetoclax resistance in primary patient samples.
Ironomycin AM5 exhibits a more potent and selective activity against breast cancer stem cells (CSCs) in vitro and in vivo, by accumulating and sequestering iron in lysosomes.
分子量 | 709 | |
分子式 | C45H73NO10 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
|
1. Garciaz S, et al. Cancer Discov. 2021 Dec 3. doi: 10.1158/2159-8290.CD-21-0522.
2. Devin J, et al. Cancer Res. 2022 Jan 25:canres.0218.2021.
3. Versini A, et al. Chemistry. 2020 Jun 10;26(33):7416-7424.
4. Mai TT, et al. Nat Chem. 2017 Oct;9(10):1025-1033.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright